95 related articles for article (PubMed ID: 8814701)
21. A novel form of fibroblast growth factor receptor 2. Alternative splicing of the third immunoglobulin-like domain confers ligand binding specificity.
Dell KR; Williams LT
J Biol Chem; 1992 Oct; 267(29):21225-9. PubMed ID: 1400433
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.
Wilson SE; Weng J; Chwang EL; Gollahon L; Leitch AM; Shay JW
Cell Mol Biol Res; 1994; 40(4):337-50. PubMed ID: 7866434
[TBL] [Abstract][Full Text] [Related]
23. Expression of FGF and FGF receptor genes in human breast cancer.
Penault-Llorca F; Bertucci F; Adélaïde J; Parc P; Coulier F; Jacquemier J; Birnbaum D; deLapeyrière O
Int J Cancer; 1995 Apr; 61(2):170-6. PubMed ID: 7705943
[TBL] [Abstract][Full Text] [Related]
24. Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer.
Zhu X; Daffada AA; Chan CM; Dowsett M
Int J Cancer; 1997 Aug; 72(4):574-80. PubMed ID: 9259393
[TBL] [Abstract][Full Text] [Related]
25. Sex hormone binding globulin mRNA in human breast cancer: detection in cell lines and tumor samples.
Moore KH; Bertram KA; Gomez RR; Styner MJ; Matej LA
J Steroid Biochem Mol Biol; 1996 Nov; 59(3-4):297-304. PubMed ID: 9010321
[TBL] [Abstract][Full Text] [Related]
26. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
[TBL] [Abstract][Full Text] [Related]
27. Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs.
Ueda T; Sasaki H; Kuwahara Y; Nezu M; Shibuya T; Sakamoto H; Ishii H; Yanagihara K; Mafune K; Makuuchi M; Terada M
Cancer Res; 1999 Dec; 59(24):6080-6. PubMed ID: 10626794
[TBL] [Abstract][Full Text] [Related]
28. Isolation of the complementary DNA encoding a mouse heparin-binding growth factor receptor with the use of a unique kinase insert sequence.
Katoh O; Hattori Y; Sasaki H; Sakamoto H; Fujimoto K; Fujii T; Sugimura T; Terada M
Cancer Res; 1993 Mar; 53(5):1136-41. PubMed ID: 8382556
[TBL] [Abstract][Full Text] [Related]
29. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells.
Savagner P; Vallés AM; Jouanneau J; Yamada KM; Thiery JP
Mol Biol Cell; 1994 Aug; 5(8):851-62. PubMed ID: 7803853
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of K-sam protein in stomach cancer.
Hattori Y; Itoh H; Uchino S; Hosokawa K; Ochiai A; Ino Y; Ishii H; Sakamoto H; Yamaguchi N; Yanagihara K; Hirohashi S; Sugimura T; Terada M
Clin Cancer Res; 1996 Aug; 2(8):1373-81. PubMed ID: 9816310
[TBL] [Abstract][Full Text] [Related]
31. [Expression of fibroblast growth factor receptors (FGFRs) mRNA in human astrocytomas].
Yamada SM; Bruner JM; Berger MS; Morrison RS
No To Shinkei; 1996 Apr; 48(4):363-70. PubMed ID: 8679334
[TBL] [Abstract][Full Text] [Related]
32. Altered expression of fibroblast growth factor receptors in human pituitary adenomas.
Abbass SA; Asa SL; Ezzat S
J Clin Endocrinol Metab; 1997 Apr; 82(4):1160-6. PubMed ID: 9100589
[TBL] [Abstract][Full Text] [Related]
33. Basic fibroblast growth factor (bFGF) and its receptor expression (bek and flg) In bone marrow stroma of murine AIDS.
Tse KF; Inayat MS; Morrow JK; DellaPuca R; Hughes NK; Gallicchio VS
Virus Res; 2004 May; 101(2):175-84. PubMed ID: 15041185
[TBL] [Abstract][Full Text] [Related]
34. Alternative and aberrant messenger RNA splicing of the mdm2 oncogene in invasive breast cancer.
Lukas J; Gao DQ; Keshmeshian M; Wen WH; Tsao-Wei D; Rosenberg S; Press MF
Cancer Res; 2001 Apr; 61(7):3212-9. PubMed ID: 11306511
[TBL] [Abstract][Full Text] [Related]
35. Two erbB-4 transcripts are expressed in normal breast and in most breast cancers.
Sawyer C; Hiles I; Page M; Crompton M; Dean C
Oncogene; 1998 Aug; 17(7):919-24. PubMed ID: 9780009
[TBL] [Abstract][Full Text] [Related]
36. Oncoprotein fos activation in epithelial-cells induces an epitheliomesenchymal conversion and changes the receptor encoded by the fgfr-2 messenger-RNA from k-sam to bek.
Scotet E; Reichmann E; Breathnach R; Houssaint E
Oncol Rep; 1995 Mar; 2(2):203-7. PubMed ID: 21597713
[TBL] [Abstract][Full Text] [Related]
37. Identification of a novel alternative splicing of human FGF receptor 4: soluble-form splice variant expressed in human gastrointestinal epithelial cells.
Takaishi S; Sawada M; Morita Y; Seno H; Fukuzawa H; Chiba T
Biochem Biophys Res Commun; 2000 Jan; 267(2):658-62. PubMed ID: 10631118
[TBL] [Abstract][Full Text] [Related]
38. A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold.
Yayon A; Zimmer Y; Shen GH; Avivi A; Yarden Y; Givol D
EMBO J; 1992 May; 11(5):1885-90. PubMed ID: 1316275
[TBL] [Abstract][Full Text] [Related]
39. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
40. Down-regulation of a novel form of fibroblast growth factor receptor 1 in human breast cancer.
Yiangou C; Cox H; Bansal GS; Coope R; Gomm JJ; Barnard R; Walters J; Groome N; Shousha S; Coombes RC; Johnston CL
Br J Cancer; 1997; 76(11):1419-27. PubMed ID: 9400937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
